EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, FATE: Fate Therapeutics

13 Mar 26 15:59
LAST:

1.170

CHANGE:
 0.00		OPEN:
1.220		HIGH:
1.230		ASK:
4.070		VOLUME:
1.73M
CHG(%):
0.00		PREV:
1.170		LOW:
1.110		BID:
4.720		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Mar 261.2201.2301.1101.1701.73M
12 Mar 261.2301.2601.1651.1701.05M
11 Mar 261.2901.3001.2101.2301.37M
10 Mar 261.3301.3801.2901.2901.24M
09 Mar 261.3201.3801.2801.3301.37M
06 Mar 261.3401.3701.2601.3301.76M
05 Mar 261.4101.4301.3401.3801.63M
04 Mar 261.4001.4801.3651.4501.37M
03 Mar 261.4501.4501.3321.3701.45M
02 Mar 261.4101.5151.4101.5001.18M

PROFILE

Name:Fate Therapeutics
About:Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Website:https://www.fatetherapeutics.com
CUSIP:31189P102
CIK:0001434316
ISIN:US31189P1021
FIGI:BBG000QP35H2
LEI:549300L14Q4UHOODLA90

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.77 
Forward P/E:-0.96 
PEG Ratio:0.06 
Price to Sales:18.38 
Price to Book:0.55 
Operating Margin:-19.39 
Return on Assets:-0.25 
Return on Equity:-0.52 
EPS Ratio:-1.45 
Revenue:8.47M 
Shares:115.35M 
Market Cap:134.96M 

TECHNICAL INDICATORS

MA5:1.245.8%
MA10:1.3213.0%
MA20:1.3818.3%
MA50:1.235.1%
MA100:1.191.5%
MA200:1.180.9%
RSI14:31.52 
WPR14:-100.00 
MTM14:-0.45
ROC14:-0.28 
ATR:0.13 
Week High:1.3817.9%
Week Low:1.115.4%
Month High:1.7044.9%
Month Low:1.110.9%
Year High:1.9465.8%
Year Low:0.6677.0%
Volatility:47.82